One reads: "could be" but would rather see: "IS".

One reads: "could be" but would rather see: "IS".

There is quite a bit of news out there that revolves around fast tracking labs for coronavirus testing this morning; here is one article from over 3 weeks ago:


The US Fast-Tracked a Coronavirus Test to Speed Up Diagnoses

The FDA has given emergency authorization to a new test that promises to help public health labs meet a potential surge in cases.

https://www.wired.com/story/the-us-fast-track...irus-test/

More:

Novacyt, Co-Diagnostics, Other Test Firms Seek Fast-Track EUA Approval From FDA For Coronavirus Dx's

CDC Shares Blueprint For Coronavirus Diagnostic With US State Laboratories

IF the company possesses a unique and inexpensive product that can effectively detect the coronavirus, has the company approached the CDC
for fast tracking? We see other companies mentioned, but not Decision Diagnostics or PharmaTech Solutions Inc.

BUT

One does read hints from the company spokesperson that the company possesses this technology:

"I am wondering if DECN has a way to quickly create a CORONAVIRUS test. I say yes"

"By the way, being THE consultant and all, have you read the landmark Japanese article "Nonlinear electrical impedance spectroscopy of viruses using very high electric fields created by nanogap electrodes.
This is the basis behind the company's Gen TBG product and could be the near term key to screening for tests for Corona virus, Bird Flu, SARS, Polio, Ebola (and Marburg)."

This could be the golden opportunity that the company could unexpectedly fall into

but

once again,

one reads: "could be" but would rather see: "IS".